To review the implications of gadolinium-based contrast agents (GBCA) usage, particularly focusing on gadolinium retention and deposition in the brain over the past decade, including potential health risks and safety concerns.
Key Findings:
Gadolinium deposition in the brain has been observed, particularly in the dentate nucleus and globus pallidus, raising concerns about long-term neurological effects.
Linear GBCA are associated with higher retention and deposition compared to macrocyclic GBCA, indicating a need for careful selection of contrast agents.
Long-term retention of gadolinium occurs preferentially in specific brain regions, independent of age or sex, suggesting a universal risk factor for patients.
Interpretation:
The findings highlight the need for careful consideration of GBCA use, especially in patients requiring multiple MRI scans, due to potential long-term effects of gadolinium retention, including neurological implications.
Limitations:
The studies primarily focus on animal models, which may not fully translate to human physiology, necessitating further research in human subjects.
Limited understanding of the long-term clinical implications of gadolinium deposition in humans, emphasizing the need for ongoing studies.
Conclusion:
Continued monitoring and research are essential to understand the implications of gadolinium retention in patients, particularly regarding safety and potential health risks, to inform clinical practice.
